{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T16:07:42Z","timestamp":1793549262100,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"am","delay-in-days":351,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006451","name":"Civil Hospices of Lyon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006451","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.autrev.2024.103529","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T04:24:33Z","timestamp":1710476673000},"page":"103529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Structural cell heterogeneity underlies the differential contribution of IL-17A, IL-17F and IL-23 to joint versus skin chronic inflammation"],"prefix":"10.1016","volume":"23","author":[{"given":"Marie","family":"Robert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Miossec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2024.103529_bb0005","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/ni.3790","article-title":"A guiding map for inflammation","volume":"18","author":"Netea","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2024.103529_bb0010","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41584-023-01007-2","article-title":"Inflammation across tissues: can shared cell biology help design smarter trials?","volume":"19","author":"Hosack","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2024.103529_bb0015","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41586-020-2424-4","article-title":"Structural cells are key regulators of organ-specific immune responses","volume":"583","author":"Krausgruber","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2024.103529_bb0020","doi-asserted-by":"crossref","first-page":"19223","DOI":"10.1038\/s41598-023-45653-8","article-title":"Differential effects of interleukin-17A and 17F on cell interactions between immune cells and stromal cells from synovium or skin","volume":"13","author":"Tout","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2024.103529_bb0025","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41584-021-00665-4","article-title":"Importance of lymphocyte-stromal cell interactions in autoimmune and inflammatory rheumatic diseases","volume":"17","author":"Noack","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2024.103529_bb0030","doi-asserted-by":"crossref","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.autrev.2024.103529_bb0035","series-title":"Histology: A text and atlas, international edition: With correlated cell and molecular biology","author":"Pawlina","year":"2019"},{"key":"10.1016\/j.autrev.2024.103529_bb0040","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nri3902","article-title":"Immunological hallmarks of stromal cells in the tumour microenvironment","volume":"15","author":"Turley","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2024.103529_bb0045","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.cell.2016.11.040","article-title":"The stromal intervention: regulation of immunity and inflammation at the epithelial-mesenchymal barrier","volume":"168","author":"Nowarski","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2024.103529_bb0050","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.stem.2021.09.001","article-title":"Multipotent stromal cells: One name, multiple identities","volume":"28","author":"Soliman","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.autrev.2024.103529_bb0055","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.it.2004.11.014","article-title":"A stromal address code defined by fibroblasts","volume":"26","author":"Parsonage","year":"2005","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2024.103529_bb0060","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41577-021-00540-z","article-title":"Fibroblasts as immune regulators in infection, inflammation and cancer","volume":"21","author":"Davidson","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2024.103529_bb0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/eji.200838232","article-title":"Fibroblasts from different sites may promote or inhibit recruitment of flowing lymphocytes by endothelial cells","volume":"39","author":"McGettrick","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2024.103529_bb0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.febslet.2004.05.040","article-title":"The local physicochemical environment conditions the proinflammatory response of endothelial cells and thus modulates leukocyte recruitment","volume":"569","author":"Nash","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.autrev.2024.103529_bb0075","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41590-020-0741-2","article-title":"The mesenchymal context in inflammation, immunity and cancer","volume":"21","author":"Koliaraki","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2024.103529_bb0080","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1038\/s41467-018-04310-9","article-title":"Comprehensive epigenetic landscape of rheumatoid arthritis fibroblast-like synoviocytes","volume":"9","author":"Ai","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2024.103529_bb0085","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41584-018-0112-7","article-title":"Pathogenic stromal cells as therapeutic targets in joint inflammation","volume":"14","author":"Dakin","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2024.103529_bb0090","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1146\/annurev-immunol-032713-120252","article-title":"Stromal cells in chronic inflammation and tertiary lymphoid organ formation","volume":"33","author":"Buckley","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2024.103529_bb0095","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","article-title":"Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry","volume":"20","author":"Zhang","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2024.103529_bb0100","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41467-018-02892-y","article-title":"Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis","volume":"9","author":"Mizoguchi","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2024.103529_bb0105","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/ard.61.11.975","article-title":"Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10","volume":"61","author":"Tolboom","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103529_bb0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/ard.34.3.219","article-title":"Proliferation of synovial lining cells and fibroblasts","volume":"34","author":"Mohr","year":"1975","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103529_bb0115","first-page":"2143","article-title":"Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium","volume":"149","author":"Firestein","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2024.103529_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013416","article-title":"Role of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression","volume":"5","author":"Toh","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2024.103529_bb0125","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13075-016-1046-6","article-title":"Interaction among activated lymphocytes and mesenchymal cells through podoplanin is critical for a high IL-17 secretion","volume":"18","author":"Noack","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2024.103529_bb0130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","article-title":"Distinct fibroblast subsets drive inflammation and damage in arthritis","volume":"570","author":"Croft","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2024.103529_bb0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2133.1983.tb07075.x","article-title":"Hyperactivity of fibroblasts cultured from psoriatic skin: I. Faster proliferation and effect of serum withdrawal","volume":"109","author":"Priestley","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2024.103529_bb0140","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.2413549","article-title":"Psoriatic fibroblasts induce hyperproliferation of normal keratinocytes in a skin equivalent model in vitro","volume":"230","author":"Saiag","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.autrev.2024.103529_bb0145","first-page":"890","article-title":"Dermal fibroblast expression of stromal cell-derived factor-1 (SDF-1) promotes epidermal keratinocyte proliferation in normal and diseased skin. Protein","volume":"6","author":"Quan","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2024.103529_bb0150","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1038\/s41467-023-39020-4","article-title":"Single cell and spatial sequencing define processes by which keratinocytes and fibroblasts amplify inflammatory responses in psoriasis","volume":"14","author":"Ma","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2024.103529_bb0155","doi-asserted-by":"crossref","first-page":"17134","DOI":"10.1038\/s41598-023-44346-6","article-title":"Integrated single-cell and spatial transcriptomics reveals heterogeneity of fibroblast and pivotal genes in psoriasis","volume":"13","author":"He","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2024.103529_bb0160","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cell.2018.08.067","article-title":"Structural remodeling of the human colonic mesenchyme in inflammatory bowel disease","volume":"175","author":"Kinchen","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2024.103529_bb0165","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41575-018-0084-8","article-title":"IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting","volume":"16","author":"Moschen","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2024.103529_bb0170","doi-asserted-by":"crossref","first-page":"8378","DOI":"10.1038\/s41598-019-44840-w","article-title":"Two phase kinetics of the inflammatory response from hepatocyte-peripheral blood mononuclear cell interactions","volume":"9","author":"Beringer","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2024.103529_bb0175","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","article-title":"T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines","volume":"183","author":"Fossiez","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2024.103529_bb0180","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/ard.2010.143768","article-title":"Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes","volume":"70","author":"Hot","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103529_bb0185","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2024.103529_bb0190","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm.3895","article-title":"IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases","volume":"21","author":"Teng","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2024.103529_bb0195","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.autrev.2013.12.004","article-title":"Th17 and regulatory T cell balance in autoimmune and inflammatory diseases","volume":"13","author":"Noack","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2024.103529_bb0200","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2024.103529_bb0205","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3389\/fmed.2018.00364","article-title":"IL-17 in rheumatoid arthritis and precision medicine: from synovitis expression to circulating bioactive levels","volume":"5","author":"Robert","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.autrev.2024.103529_bb0210","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood-2010-01-263509","article-title":"Human fibroblasts support the expansion of IL-17-producing T cells via up-regulation of IL-23 production by dendritic cells","volume":"116","author":"Schirmer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2024.103529_bb0215","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.4049\/jimmunol.0801967","article-title":"Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes","volume":"182","author":"Zrioual","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2024.103529_bb0220","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/annrheumdis-2011-200867","article-title":"IL-17 and tumour necrosis factor \u03b1 combination induces a HIF-1\u03b1-dependent invasive phenotype in synoviocytes","volume":"71","author":"Hot","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103529_bb0225","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13075-015-0688-0","article-title":"Ectopic lymphoid neogenesis is strongly associated with activation of the IL-23 pathway in rheumatoid synovitis","volume":"17","author":"Ca\u00f1ete","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2024.103529_bb0230","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.imlet.2009.10.012","article-title":"IL-23 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-kappaB signal pathways","volume":"127","author":"Li","year":"2010","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2024.103529_bb0235","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2024.103529_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155357","article-title":"Synergistic induction of IL-23 by TNF\u03b1, IL-17A, and EGF in keratinocytes","volume":"138","author":"Ehst","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2024.103529_bb0245","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41467-024-44994-w","article-title":"Single-cell analysis of psoriasis resolution demonstrates an inflammatory fibroblast state targeted by IL-23 blockade","volume":"15","author":"Francis","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2024.103529_bb0250","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fimmu.2015.00151","article-title":"Differential effects of IL-17A and TNF-\u03b1 on osteoblastic differentiation of isolated Synoviocytes and on bone explants from arthritis patients","volume":"6","author":"Osta","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103529_bb0255","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cyto.2004.03.002","article-title":"Combination of the pro-inflammatory cytokines IL-1, TNF-alpha and IL-17 leads to enhanced expression and additional recruitment of AP-1 family members, Egr-1 and NF-kappaB in osteoblast-like cells","volume":"26","author":"Granet","year":"2004","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2024.103529_bb0260","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3389\/fimmu.2014.00425","article-title":"Effects of interleukin-17A on osteogenic differentiation of isolated human mesenchymal stem cells","volume":"5","author":"Osta","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103529_bb0265","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bone.2016.01.010","article-title":"Proinflammatory T cells and IL-17 stimulate osteoblast differentiation","volume":"84","author":"Croes","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.autrev.2024.103529_bb0270","doi-asserted-by":"crossref","first-page":"5950395","DOI":"10.1155\/2017\/5950395","article-title":"Different modulatory effects of IL-17, IL-22, and IL-23 on osteoblast differentiation","volume":"2017","author":"Zhang","year":"2017","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.autrev.2024.103529_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102760","article-title":"Exploring IL-17 in spondyloarthritis for development of novel treatments and biomarkers","volume":"20","author":"Groen","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2024.103529_bb0280","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41584-019-0294-7","article-title":"The IL-23-IL-17 pathway as a therapeutic target in axial spondyloarthritis","volume":"15","author":"Sieper","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2024.103529_bb0285","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/ard.24.5.481","article-title":"Microradiographic study of the intervertebral bridges in ankylosing spondylitis and in the normal sacrum","volume":"24","author":"Fran\u00e7ois","year":"1965","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103529_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102429","article-title":"Critical role of interleukin (IL)-17 in inflammatory and immune disorders: an updated review of the evidence focusing in controversies","volume":"19","author":"Ruiz de Morales","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2024.103529_bb0295","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.3389\/fimmu.2019.01726","article-title":"Additive or synergistic interactions between IL-17A or IL-17F and TNF or IL-1beta depend on the cell type","volume":"10","author":"Noack","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103529_bb0300","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.3389\/fimmu.2018.03170","article-title":"Blockade of store-operated calcium entry reduces IL-17\/TNF cytokine-induced inflammatory response in human myoblasts","volume":"9","author":"Beringer","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103529_bb0305","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/cei.13140","article-title":"Synergistic effect of interleukin-17 and tumour necrosis factor-\u03b1 on inflammatory response in hepatocytes through interleukin-6-dependent and independent pathways","volume":"193","author":"Beringer","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2024.103529_bb0310","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/cei.13316","article-title":"IL-17 and TNF-\u03b1 co-operation contributes to the proinflammatory response of hepatic stellate cells","volume":"198","author":"Beringer","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2024.103529_bb0315","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/annrheumdis-2011-200468","article-title":"Combination of IL-17 and TNFalpha induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells","volume":"71","author":"Hot","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103529_bb0320","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41584-019-0243-5","article-title":"Systemic effects of IL-17 in inflammatory arthritis","volume":"15","author":"Beringer","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2024.103529_bb0325","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.3389\/fimmu.2020.01998","article-title":"Synergistic interaction between high bioactive IL-17A and joint destruction for the occurrence of cardiovascular events in rheumatoid arthritis","volume":"11","author":"Robert","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103529_bb0330","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13075-022-02904-9","article-title":"Synoviocytes and skin fibroblasts show opposite effects on IL-23 production and IL-23 receptor expression during cell interactions with immune cells","volume":"24","author":"Noack","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2024.103529_bb0335","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/cei.12830","article-title":"Role of podoplanin in the high interleukin-17A secretion resulting from interactions between activated lymphocytes and psoriatic skin-derived mesenchymal cells","volume":"186","author":"Noack","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2024.103529_bb0340","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41586-021-03188-w","article-title":"Skin-resident innate lymphoid cells converge on a pathogenic effector state","volume":"592","author":"Bielecki","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2024.103529_bb0345","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1126\/science.adi8885","article-title":"Divergent molecular networks program functionally distinct CD8(+) skin-resident memory T cells","volume":"382","author":"Park","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.autrev.2024.103529_bb0350","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41586-019-1844-5","article-title":"Somatic inflammatory gene mutations in human ulcerative colitis epithelium","volume":"577","author":"Nanki","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2024.103529_bb0355","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/ar2337","article-title":"Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts","volume":"9","author":"Muller-Ladner","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2024.103529_bb0360","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/ard.2007.082081","article-title":"Abundant expression of the interleukin (IL)23 subunit p19, but low levels of bioactive IL23 in the rheumatoid synovium: differential expression and Toll-like receptor-(TLR) dependent regulation of the IL23 subunits, p19 and p40, in rheumatoid arthritis","volume":"68","author":"Brentano","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103529_bb0365","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.4049\/jimmunol.1000148","article-title":"Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model","volume":"186","author":"Nakajima","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2024.103529_bb0370","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.autrev.2016.09.015","article-title":"Are psoriasis and psoriatic arthritis the same disease? The IL-23\/IL-17 axis data","volume":"16","author":"Sakkas","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2024.103529_bb0375","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41584-018-0091-8","article-title":"Effects of the IL-23-IL-17 pathway on bone in spondyloarthritis","volume":"14","author":"Gravallese","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2024.103529_bb0380","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2024.103529_bb0385","article-title":"Serum biomarkers and their relationship to axial spondyloarthritis associated with inflammatory bowel diseases","volume":"23","author":"Ondrej\u010d\u00e1kov\u00e1","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2024.103529_bb0390","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa2102383","article-title":"Bimekizumab versus Secukinumab in Plaque Psoriasis","volume":"385","author":"Reich","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2024.103529_bb0395","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cyto.2018.08.025","article-title":"Differential efficacy of biologic treatments targeting the TNF-\u03b1\/IL-23\/IL-17 axis in psoriasis and psoriatic arthritis","volume":"111","author":"Furue","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2024.103529_bb0400","doi-asserted-by":"crossref","first-page":"iv4","DOI":"10.1093\/rheumatology\/keab266","article-title":"IL-23 orchestrating immune cell activation in arthritis","volume":"60","author":"Najm","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2024.103529_bb0405","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20192048","article-title":"Interleukin-17 in rheumatoid arthritis: trials and tribulations","volume":"217","author":"Taams","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2024.103529_bb0410","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/annrheumdis-2018-214943","article-title":"Efficacy and safety of bimekizumab as add-on therapy for rheumatoid arthritis in patients with inadequate response to certolizumab pegol: a proof-of-concept study","volume":"78","author":"Glatt","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103529_bb0415","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/gut.52.1.65","article-title":"Increased expression of interleukin 17 in inflammatory bowel disease","volume":"52","author":"Fujino","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2024.103529_bb0420","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn\u2019s disease: unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2024.103529_bb0425","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/ajg.2016.298","article-title":"A randomized, double-blind, placebo-controlled phase 2 study of Brodalumab in patients with moderate-to-severe Crohn\u2019s disease","volume":"111","author":"Targan","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2024.103529_bb0430","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1126\/science.aao1503","article-title":"CX3CR1(+) mononuclear phagocytes control immunity to intestinal fungi","volume":"359","author":"Leonardi","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.autrev.2024.103529_bb0435","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1221789","article-title":"Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis","volume":"336","author":"Iliev","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.autrev.2024.103529_bb0440","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.humimm.2020.02.008","article-title":"Circulating IFN-\u03b3 producing CD4+ T cells and IL-17A producing CD4+ T cells, HLA-shared epitope and ACPA may characterize the clinical response to therapy in rheumatoid arthritis patients","volume":"81","author":"Alvandpur","year":"2020","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2024.103529_bb0445","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1136\/annrheumdis-2014-207110","article-title":"A cell-based bioassay for circulating bioactive IL-17: application to destruction in rheumatoid arthritis","volume":"74","author":"Ndongo-Thiam","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103529_bb0450","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/art.40580","article-title":"ABT-122, a bispecific dual variable domain immunoglobulin targeting tumor necrosis factor and interleukin-17A, in patients with rheumatoid arthritis with an inadequate response to methotrexate: a randomized","volume":"70","author":"Genovese","year":"2018","journal-title":"Double-Blind Study Arthritis Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899722400020X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899722400020X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T17:24:19Z","timestamp":1715361859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899722400020X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S156899722400020X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103529","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural cell heterogeneity underlies the differential contribution of IL-17A, IL-17F and IL-23 to joint versus skin chronic inflammation","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103529"}}